Literature DB >> 17307610

Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case.

Figen Cizmeci Senel1, Umut Saracoglu Tekin, Ahmet Durmus, Bora Bagis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17307610     DOI： 10.1016/j.joms.2006.10.043

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  7 in total

Review 1.  Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.

Authors:  Sabrina Crépin; Marie-Laure Laroche; Bernard Sarry; Louis Merle
Journal:  Eur J Clin Pharmacol       Date:  2010-05-01       Impact factor: 2.953

Review 2.  Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Authors:  Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Cochrane Database Syst Rev       Date:  2017-12-18

3.  Localized osteomyelitis of the mandible secondary to dental treatment: report of a case.

Authors:  Saeed Nezafati; Mohammad Ali Ghavimi; Amir Saeed Yavari
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2009-06-05

Review 4.  Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.

Authors:  Giuseppe Ficarra; Francesco Beninati
Journal:  Head Neck Pathol       Date:  2007-12-05

5.  Total mandibular reconstruction following diffuse sclerosing osteomyelitis.

Authors:  Jan Rustemeyer; Birte Julia Siegmund; Yunus Okcu; Alexander Busch
Journal:  Oral Maxillofac Surg       Date:  2018-10-16

6.  Bisphosphonate - related osteonecrosis of the jaws: the point of view of the oral pathologist.

Authors:  Giuseppe Ficarra; Francesco Beninati
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

Review 7.  Clodronic acid formulations available in Europe and their use in osteoporosis: a review.

Authors:  Bruno Frediani; Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.